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ORIGINAL ARTICLEThe complex genetic region conferring transferable antibiotic resistance in
multidrug-resistant and extremely drug-resistant Klebsiella pneumoniae
clinical isolatesM. T. Moghadam1,2, A. Shariati1,2, S. Mirkalantari3 and A. Karmostaji4
1) Faculty of Medicine, Microbiology Department, 2) Student Research Committee, 3) Faculty of Medicine, Microbiology Department, Iran University of Medical
Sciences, Tehran, Iran and 4) Hormozgan Health Institute, University of Medical Sciences, Bandar Abbas, IranAbstractAntibiotic resistance due to transferable resistance genes is one of the most important concerns in Klebsiella pneumoniae isolated from
nosocomial infections. Eighty-eight K. pneumoniae isolates were confirmed through biochemical methods. In addition, antimicrobial
susceptibility testing was performed using a disc-diffusion method. Extended-spectrum β-lactamase production among the isolates was
screened using a double-disc synergism test, and the resistance genes were identified using PCR. The eight loci for multiple-locus variable
number tandem repeat analysis (MLVA) genotyping were selected along with the primers. According to our findings, neomycin (5; 5.6%)
and carbapenems (10; 11.3%) showed the most remarkable inhibitory effect but co-trimoxazole (46; 52.2%) was the least effective
antibiotic against K. pneumoniae isolates. blaCTX-M-1, qnrA, qnrB, qnrS, intI, intII, aac3 and aac6 were detected in 30 (34%), 5 (5.6%), 29
(32.9%), 23 (26.1%), 88 (100%), 72 (81.8%), 26 (29.5%) and 28 (31.8%) of the 88 isolates, respectively. But none of the K. pneumoniae
isolates expressed the intIII gene. Using MLVA, 23 MLVA types and eight clusters were identified. Extended-spectrum β-lactamase-
producing K. pneumoniae isolates were classified into two clonal complexes. Effective strategies for infection control should be applied to
monitor and control the spread of multidrug-resistant isolates by the resistance genes located on the mobile genetic elements.
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E-mail: Mirkalantari.sh@iums.ac.irIntroductionKlebsiella species form a group of Gram-negative bacilli that are
highly prevalent and can be found in different areas, including
the human body and the environment. Klebsiella pneumoniae is
one of the most important bacteria and is known as the third
major cause of hospital-acquired infections, meningitis, pneu-
monia, bacteraemia, wound infections and urinary tract in-
fections [1–4]. Klebsiella pneumoniae producing extended-
spectrum β-lactamases (ESBLs) show resistance to mostThis is an open access artiantibiotics [5,6]. One member of the Class A ESBLs, the CTX-
M, also showed a high-level resistance to cefotaxime, ceftriax-
one, cefepime and cefpirome. CTX-M-type enzymes have been
among widespread variants of the ESBL group; however, the
incidence of ESBL TEM and SHV derivatives remained un-
changed [7,8]. The ESBL-producing strains develop resistance
to other antibiotics such as aminoglycosides, tetracyclines and
sulfonamides, whereas bacteria that produce the CTX-M
exhibit co-resistance to quinolones as well [8,9]. Quinolones
enter bacteria directly through the cytoplasmic membrane and
target type II topoisomerases, DNA gyrase and topoisomerase
IV, and disrupt DNA replication [10]. QnrA, a plasmid-encoded
quinolone resistance protein, is a member of the pentapeptide
repeat protein family that protects topoisomerase IV and gyrase
from quinolone binding [11–13]. The prevalence of ESBL- and
Qnr-positive strains has been reported to be 4%–48% in
different studies [14–16]. Plasmids that carry a qnrANew Microbe and New Infect 2020; 36: 100693
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TABLE 1. Antibiotic resistance patterns of Klebsiella pneumoniae clinical isolates from five hospitals
Antibiotics
Total samples
ESBL-positive (30 isolates) ESBL-negative (58 isolates) p value*Resistance Intermediate Sensitive
Amoxicillin/clavulanic acid 26 (29.5%) 8 (9.0%) 54 (61.3%) 12 (40.0%) 14 (24.1%) 0.02
Ceftazidime 34 (38.6%) 2 (2.2%) 52 (59.0%) 23 (76.6%) 11 (18.9%) < 0.001
Cefotaxime 37 (42.0%) 1 (1.1%) 50 (56.8%) 22 (73.3%) 15 (25.8%) < 0.001
Cefepime 22 (25.0%) 1 (1.1%) 65 (73.8%) 14 (46.6%) 8 (13.7%) < 0.001
Ceftriaxone 40 (45.4%) 4 (4.5%) 44 (50.0%) 22 (73.3%) 18 (31.0%) < 0.001
Aztreonam 38 (43.1%) 2 (2.2%) 48 (54.5%) 21 (70.0%) 17 (29.3%) < 0.001
Ertapenem 11 (12.5%) 5 (5.6%) 72 (81.8%) 4 (13.3%) 7 (12.0%) 0.10
Imipenem 10 (11.3%) 3 (3.4%) 75 (85.2%) 6 (20.0%) 4 (6.8%) 0.01
Norfloxacin 27 (30.6%) 1 (1.1%) 60 (68.1%) 10 (33.3%) 17 (29.3%) 0.11
Levofloxacin 19 (21.5%) 1 (1.1%) 68 (77.2%) 7 (23.3%) 12 (20.6%) 0.13
Nalidixic acid 33 (37.5%) 11 (12.5%) 44 (50.0%) 13 (43.3%) 20 (34.4%) 0.06
Ofloxacin 23 (26.1%) 5 (5.6%) 60 (68.1%) 9 (30.0%) 14 (24.1%) 0.06
Ciprofloxacin 23 (26.1%) 1 (1.1%) 64 (72.7%) 9 (30.0%) 14 (24.1%) 0.05
Amikacin 18 (20.4%) 2 (2.2%) 68 (77.2%) 13 (43.3%) 5 (8.6%) < 0.001
Tetracycline 25 (28.4%) 1 (1.1%) 62 (70.4%) 9 (30.0%) 16 (27.5%) 0.12
Gentamicin 24 (27.2%) 2 (2.2%) 62 (70.4%) 16 (53.3%) 8 (13.7%) < 0.001
Tobramycin 24 (27.2%) 2 (2.2%) 62 (70.4%) 16 (53.3%) 8 (13.7%) < 0.001
Streptomycin 38 (43.1%) 3 (3.4%) 47 (53.4%) 20 (66.6%) 18 (31.0%) < 0.001
Kanamycin 29 (32.9%) 4 (4.5%) 55 (62.5%) 15 (50.0%) 14 (24.1%) < 0.001
Neomycin 5 (5.6%) 5 (5.6%) 78 (88.6%) 2 (6.6%) 3 (5.1%) 0.15
Co-trimoxazole 46 (52.2%) 0 (0.0%) 42 (47.7%) 18 (60.0%) 28 (48.2%) 0.10
Abbreviation: ESBL, extended-spectrum β-lactamase.
*Value of p is for a comparison of resistance among ESBL-producers with that among non-producers.
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such as bla genes (β-lactamases) and aac (encodes an acetyl-
transferase) [10,17]. ACCs (Aminocyclopropane-1-Carbox-
ylate Synthase) are a group of the most common
aminoglycoside-modifying enzymes in Gram-negative bacteria,
particularly K. pneumoniae; they are subdivided into four groups
containing AAC(1), AAC(2ʹ), AAC(3) and ACC(6ʹ) [18].
Although integrons are not mobile genetic elements they can be
transmitted by transposons, plasmids and chromosomes, and
easily spread among Gram-negative bacteria. The role of inte-
grons in the development of multidrug-resistant (MDR) strains
is the issue that causes concern about the presence of integrons
in bacteria [19, 20]. The emergence of MDR and extensively
drug-resistant (XDR) bacteria, particularly K. pneumoniae, is of
serious concern in the development of new therapies for
bacterial infections. This study is designed to discover the
patterns of resistance against commonly used antibiotics in
different lineages of K. pneumoniae clinical isolates with special
attention to fluoroquinolones, carbapenems, β-lactams and
aminoglycosides.
Materials and methodsBacterial isolates
A total of 88 non-duplicate clinical isolates of K. pneumoniae
were selected from urine, blood and sputum samples that were
collected from five Tehran hospitals in Iran, over a period of 1
year (2017–2018). Samples were taken from both inpatients
and outpatients who were hospitalized in the infectious and
burns wards. The following standard characteristics of clinical© 2020 Published by Elsevier Ltd, NMNI, 36, 100693
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/liceK. pneumoniae were used to identify all isolates by biochemical
methods [21].
Antimicrobial susceptibility test
An antibiotic susceptibility test was carried out using the disc-
diffusion method according to the Clinical and Laboratory
Standard Institute guideline (CLSI) and the Committee on
Antimicrobial Susceptibility Testing (there is no standard for
neomycin in Enterobacteriaceae in the CLSI) [22]. All
K. pneumoniae isolates were tested for their susceptibility
profiles against the antimicrobial agents shown in Table 1. The
prevalence of MDR and XDR in these isolates was also inves-
tigated. MDR was defined as acquired resistance to at least one
agent in three or more antimicrobial categories. XDR was
defined as bacterial isolates remain susceptible to only one or
two antimicrobial categories [23,24].
Screening of ESBL phenotype
The phenotypic confirmatory test was performed using
cefotaxime-clavulanic acid or ceftazidime-clavulanic acid as a
two-disc synergism versus ceftazidime or cefotaxime alone. If
the inhibition zone around the synergism discs was 5 mm
compared with ceftazidime or cefotaxime alone, then the
isolate was found to be ESBL-producing. Klebsiella pneumoniae
ATCC 700603 and Escherichia coli ATCC 25922 were used as
positive and negative controls, respectively [21].
Detection of resistance genes
Antibiotic resistance genes and integrons (Table 2) were
detected using standard PCR amplification. To extract DNA,
the DNA extraction kit (GeNet Bio Company, Daejeon, Korea;nses/by-nc-nd/4.0/).
TABLE 2. Primers for cephalosporin-, aminoglycoside- and fluoroquinolone-resistance genes




























NMNI Moghadam et al. Complex genetic region conferring resistance in K. pneumoniae 3Cat. No, K-3000) was used according to the manufacturer’s
guidelines. PCR were carried out in a final volume of 25 μL by
using 3 μL DNA solution, 12.5 μL of Master Mix (Qiagen
HotStar Taq polymerase), 1 μL of 10 pmol of each primer and
7.5 μL of distilled water. Amplification reactions were per-
formed on a thermal cycler (model) with the following PCR
conditions: a denaturation step at 94°C for 5 min, followed by
30 cycles of denaturation at 94°C for 1 min, primer annealing at
51°C to 60°C for 40 s, and final extension step at 72°C for 5
min. Eventually, PCR products were detected using electro-
phoresis on a 1% agarose gel, visualized by safe stain and illu-
minated by UV light.
Multiple-locus variable number tandem repeat analysis
(MLVA) assay
For typing of all ESBL-producing K. pneumoniae isolates the
MLVA, using loci A, D, E, H, I, J, K and L was used as defined
previously [25]. The number of repeats can be easily conducted
from the PCR product sizes by manual reading. To convert the
product sizes into repeat numbers, a principle defined in a pre-
vious study was applied [25]. A dendrogram of genetic relation-
ships was also produced using the unweighted pair groupmethod
with arithmetic averages (UPGMA) based on allelic profiles. In
addition, the minimum spanning tree was created with a cate-
gorical ratio based on the allelic profiles of the K. pneumoniae
isolates. Simpson’s index of diversity was used to calculate the
diversity of ESBL-producing isolates. This index has a range be-
tween 0 and 1, where scores of 1 or near to 1 indicate high di-
versities and 0 or close to 0 indicate low diversities.Statistical analysis
The collected data were entered into a database using SPSS
version 22 for K. pneumoniae isolates. The interpretation of the
results was based on frequencies. Carmer’s V test was exertedThis is an open access articto investigate the relationship between age of patients and
different antibiotic resistance rates. A value of p < 0.05 was
considered statistically significant for association between all
antibiotics, resistance genes and clinical isolates by the chi-
square test.ResultsIn all, 88 K. pneumoniae were isolated: 83 from urine (94.3%),
four from sputum (4.5%) and one from blood (1.1%). Of all
samples, 68 (77.2%) K. pneumoniae isolates were recovered
from female individuals and the other 20 (22.7%) samples were
isolated from male individuals. Twenty-eight (31.8%) isolates
out of 88 samples were collected from outpatients and 60
(68.1%) isolates were from inpatients. In the present study, the
age of patients from whom the samples were collected ranged
from 1 to 92 (48.63 ± 27.54) years. Antibiotic susceptibility
tests demonstrated that the highest antibiotic resistance in
K. pneumoniae isolates was against co-trimoxazole, to which 46
(52.2%) isolates were resistant. The most effective antibiotic
against K. pneumoniae isolates was neomycin. Imipenem
(85.2%), ertapenem (81.8%), levofloxacin (77.2%), amikacin
(77.2%), ciprofloxacin (72.7%), gentamicin (70.4%) and tetra-
cycline (70.4%) were effective against more than 70.0% of the
K. pneumoniae isolates (Table 1). The results also showed that
imipenem remained more effective than ertapenem. A signifi-
cant association was observed between different antibiotic
resistance and the hospital from which the samples were
collected. There was no relationship between different age of
patients and different antibiotic resistance rates. Most resistant
samples were isolated from hospital 4, but more samples that
were susceptible to all antibiotics were isolated from hospital 2
(p  0.05). Among 88 K. pneumoniae isolates, 43 (48.8%) and© 2020 Published by Elsevier Ltd, NMNI, 36, 100693
le under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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of MDR and XDR K. pneumoniae was isolated from hospital 4
whereas the isolates with the lowest resistance belonged to
hospital 3. Data analysis showed a significant correlation be-
tween MDR and XDR isolates and the hospital that provided
the samples (p  0.05). In this study, 30 (34%) isolates were
phenotypically ESBL-producing. After PCR detection, the
expression of blaCTX-M-1 genes was confirmed in all pheno-
typically positive ESBL isolates. The result of antibiotic resis-
tance in K. pneumoniae isolates demonstrated that resistance
to all antibiotics in ESBL-producing K. pneumoniae was higher
than in non-ESBL K. pneumoniae (Table 1). Among the ESBL-
positive isolates, 19 (63.33%) were MDR, and 11 (36.67%)
isolates were detected as XDR (supplementary table).
Therefore, there was a remarkable relationship between ESBL-
positive isolates, MDR, and XDR isolates (P  0.05). Among
the 88 isolates, 35 (39.7%) plasmid-mediated quinolone
resistance-positive isolates were detected. The presence of
qnrA, qnrB and qnrS genes were observed in 5 (5.6%), 29
(32.9%) and 23 (26.1%) of the isolates, respectively. Among
these 35 plasmid-mediated quinolone resistance-positive iso-
lates, 22 (81.48%) and 10 (37.03%) isolates were MDR and
XDR, respectively. Data analysis showed a significant rela-
tionship between the presence of qnr genes and MDR and
XDR isolates (p  0.05). Furthermore, a direct association
between the expression of qnr genes and resistance to qui-
nolone and fluoroquinolones was observed. Among qnr genes,
the qnrB made the greatest contribution to resistance to qui-
nolone and fluoroquinolones (p  0.05). The association of
qnrS and qnrB detected in some isolates has raised the level of
resistance to quinolone antibiotics, suggesting that the syner-
gistic effects of qnrS with qnrB in isolates may increase defence
against quinolones (see Supplementary material, Table S1).
Overall, screening the isolates for the presence of the int genes
revealed that all isolates (100%) contained the intI gene.
Seventy-two (81.8%) of the 88 isolates possessed intII and intI,
but intIII was not identified in any of the K. pneumoniae isolates.
In addition, resistance to some antibiotics such as tetracycline,
gentamycin, tobramycin, ciprofloxacin, aztreonam, ceftriax-
one, cefotaxime and ceftazidime was significantly associated
with the presence of class II integron (p  0.05). Furthermore,
a remarkable relationship between the presence of integron
class II and existence of ESBL, aac(60)-Ib-cr, and aac(3)-II-cr was
observed (p  0.05). A higher prevalence of class II integron
was identified in inpatients than outpatients (p  0.05).
Twenty-eight (31.8%) isolates were positive for the aac(60)-Ib-
cr gene, but 26 (29.5%) isolates harboured the aac(3)-II-cr gene.
Among the total of 88 K. pneumoniae isolates, 26 (29.5%)
possessed both aac(60)-Ib-cr and aac(3)-II-cr genes. Statistical
analysis revealed that not only were aac(60)-Ib-cr and aac(3)-II-cr© 2020 Published by Elsevier Ltd, NMNI, 36, 100693
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/liceremarkably related to some aminoglycoside antibiotic resis-
tance, including amikacin, gentamicin, tobramycin and strep-
tomycin, but also a correlation between aac(60)-Ib-cr and
aac(3)-II-cr and blaCTX-M-1, qnrB and intII genes was found
(p  0.05). In the present study, 11 (12.5%) K. pneumoniae
isolates were found that harboured a complex of resistance
genes together that were easily transferable (blaCTX-M-1/aac/
qnr/int); all 11 isolates were MDR or XDR and high-level
antibiotic resistance was observed in them. However, in our
study, no significant difference was found between the rates of
blaCTX-M-1, aac and qnr genes among hospitalized patients and
outpatients (p > 0.05). Overall, among the variable-number of
tandem repeat (VNTR) loci, ‘A’ locus was found as the most
frequent VNTRs, containing seven different alleles. D and E
loci contained only three different alleles and showed the
lowest discriminatory power. The UPGMA dendrogram
showed that 30 K. pneumoniae isolates were discriminated into
23 different MLVA types and eight clusters. Minimum spanning
tree analysis of the 30 K. pneumoniae indicated that different
isolates were co-circulating within the hospitals. These isolates
fell into two different clonal complexes. These two clonal
complexes consisted of isolates circulating among the three
hospitals from the five hospitals under study, and 20 singletons
(Fig. 1).DiscussionIn this study, antibiotic resistance patterns showed that these
bacteria have high resistance to cephalosporins and aztreo-
nam, which can be attributed to the production of ESBLs in
these bacteria. Also, most of the resistant isolates were
collected from hospital 4 (n = 15), whereas wild isolates
mainly came from hospital 2 (n = 1). This may be a result of
patient recruitment, because the patient samples in hospital 4
were mainly from inpatients, while those in hospital 2 were
mainly from outpatients. Similar to our findings, Bina et al.
reported that the highest and lowest resistance rates in their
study were related to piperacillin (60.6%) and imipenem
(13.9%), respectively [26]. The results of a study by Kiaei et al.
also showed that resistance to cephalosporins was high, and
imipenem had the best inhibitory effect on K. pneumoniae.
Furthermore, they reported that other antibiotics, such as
fosfomycin, ertapenem and gentamicin, had a good effect on
isolates, with 8%, 9% and 8% resistance, respectively [24]. In a
previous study in Iran, the rate of resistance of K. pneumoniae
isolates to the antibiotic imipenem was 7.2%, which is less
than the resistance obtained from the present study; it can be
concluded that resistance to carbapenems is increasing in Iran
[27]. The prevalence of carbapenem-resistant K. pneumoniaenses/by-nc-nd/4.0/).
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reported in China; however, the rate of MDR strains in the
Chinese study was 46.2%, which is close to our finding [28].
Our results also showed that carbapenems and neomycin
together had the best performance compared with other
antibiotics on isolated bacteria, although 11.3% resistance to
imipenem and 12.5% resistance to ertapenem was observed,
which can be indicative of the increased prevalence of resis-
tance to carbapenems in K. pneumoniae in Tehran hospitals
compared with previous studies [29,30]. Due to the good
performance of carbapenems in controlling the MDR bacteria,
spreading resistance to these antibiotics can increase the
prevalence of XDR K. pneumoniae isolates, which increases
the cost and duration of treatment. Also, the emergence of
XDR K. pneumoniae isolates has been observed in different
parts of the world [31,32]. Nevertheless, carbapenems have
been significantly effective on K. pneumoniae isolates in various
regions of the world as reported in the studies by Zhang et al.
and Marsh et al. [33,34]. The results of the present study
showed that 34% of our strains were ESBL producers, which
is much lower than other reports from different countries. A
study by Taati et al. showed that 60.7% of the clinical isolatesFIG. 1. Dendrogram showing the cluster analysis of 30 extended-spectrum β
multiple-locus variable number tandem repeat analysis (MLVA) profile. I =
fections), II = numbers of different hospitals, III = M (multidrug resistance), IV
number of tandem repeat markers.
This is an open access articof K. pneumoniae produced ESBL, which is higher than the
results of the present study, and confirms that resistance can
vary even in different cities of a country [35]. In India, the rate
of ESBL-positive K. pneumoniae was reported to be 73.28% in
2010 [36]. Aljanaby et al. from Iraq reported that 81.39% of
the K. pneumoniae isolates were ESBL producers [37]. How-
ever, some studies showed a similar prevalence of ESBL genes
in K. pneumoniae isolates such as the study conducted by
Zhang et al. [33]. This discrepancy between the reported
frequencies of ESBL isolates in different regions of the world
could be dependent on several factors, including the drug
abuse pattern, differences in virulence strains in terms of their
degrees, antimicrobial stewardship programme, geographical
diversity and the practices applied for control of infection. All
ESBL-positive isolates also had a blaCTX-M-1 gene, indicating
that the presence of this resistance gene is the most effective
factor in representing the ESBL phenotype. Our results and
other studies [21,38] have shown that the rate of resistance
to antibiotics in ESBL-producing K. pneumoniae is higher than
in ESBL-negative isolates. These bacteria have high potential
to gain resistance to other antibiotic families and the treat-
ment of infections caused by them is very difficult. The-lactamase (ESBL) -positive Klebsiella pneumoniae isolates based on the
HAI (hospital-acquired infections) and OPD (community-acquired in-
= X (extreme drug resistance), V to XII = different alleles of variable
© 2020 Published by Elsevier Ltd, NMNI, 36, 100693
le under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
FIG. 2. Minimum spanning tree representation of the multiple-locus
variable number tandem repeat analysis (MLVA) clustering of the 30
ESBL-positive Klebsiella pneumoniae clinical isolates isolated from pa-
tients in five hospitals of Tehran. Each circle represents a unique ge-
notype, numbers under the circles represent the number of hospitals.
The colour halo around the circles corresponds to CCs. Circles
without a colour halo represent singletons. Numbers on the lines show
the number of loci that are different between two MLVA profiles.
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5.6%, 32.9% and 26.1%, respectively. Before screening was
introduced, the qnr plasmid-borne mechanism was a major
concern for increasing antibiotic resistance because the
placement of other genes on these plasmids facilitates their
transfer from one isolate to another. Similar to our finding,
Kiaei et al. reported that qnrB was the dominant gene among
the qnr genes and the prevalences of qnrB and qnrS were 30%
and 6.7%, respectively [24]. Furthermore, the study that was
performed by Benaicha et al. showed that qnrB (11.86%) was
the most frequent gene among the qnr genes and the preva-
lence of qnrS was reported to be 5.93% [39]. It is noteworthy
that in this study, 100% of isolates contained intI, and 81.8%
possessed intII, but intIII was not found in any of the isolates.
The prevalences of intI (46%) and intII (40%) genes were lower
in our previous study [40], but the reported significant as-
sociations between resistance to many of the tested antibi-
otics and the presence of integrons were similar to the
present study [40]. In another study it was reported that the
frequency of class I, II and III integrons among 37 MDR
K. pneumoniae were 27 (72.9%), 19 (51.3%) and 3 (8.1%),
respectively, which is different from our findings [19]. The
high prevalence of integrons in K. pneumoniae especially
among hospitalized patients suggests the role of integrons as
mobile genetic elements in antibiotic resistance. In this
research, 31.8% and 29.5% of K. pneumoniae isolates repre-
sented aac(60)-Ib-cr and aac(3)-II-cr, respectively. In Iran, a
study on certain clinical populations reported a high preva-
lence of aac(60)-Ib-cr (74%) and aac(3)-II-cr (73%) [41]. These
results were comparable to those obtained by El-Badawy et al.
who studied the prevalence of aac(60)-Ib-cr and aac(3)-II-cr
among clinical K. pneumoniae isolates, and found that 88% and
58% of K. pneumoniae isolates causing infection were aac(60)-
Ib-cr and aac(3)-II-cr-positive [42]. Low prevalence rates for
acc(60)-Ib and acc(30)-II among K. pneumoniae isolates were also
reported by Liang et al., which is similar to our findings [43].
The present study also determined that the tested
aminoglycoside-resistant K. pneumoniae isolates were positive
for aac(60)-Ib-cr and aac(3)-II-cr, which has been previously
observed [42,43]. MLVA analysis of this study showed 23
MLVA types among 30 Klebsiella isolates. This genetic diversity
has also been described in previous studies [25,44]. As shown
in Fig. 2, most of the isolates were categorized into singleton
isolates. This genetic heterogeneity can be a serious challenge
to the infection control processes, in particular the circulation
of the same genotypes among isolates of hospital and com-
munity infections (31, 60 and 33; 38 and 2; 66, 67, 68 and 125;
and 74 isolates) as shown in the UPGMA dendrogram, there is
not only evidence for gene transfer among different hospitals,© 2020 Published by Elsevier Ltd, NMNI, 36, 100693
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licebut also there is the risk of transmission of these resistance
genes to community isolates. Furthermore, the location of
resistance genes in mobile genetic elements such as integrons
and plasmids proposed horizontal transmission of these
resistance elements. In this study, only the ESBL-positive
isolates were MLVA typed and therefore the discriminatory
power of this MLVA scheme as Simpson’s index of diversity
(0.84) is less than expected. However, the selection of five
different hospitals has improved the discriminatory power.
The results showed that use of drugs has high limitations.
ESBL-producing strains have the potential to acquire resis-
tance to other antibiotic classes, including fluoroquinolones
and aminoglycosides. One of the main causes of antibiotic
resistance is mobile genetic elements such as integrons that
spread easily among bacteria and can produce MDR bacteria
with multiple resistance genes. However, low resistance to
imipenem and ertapenem can indicate the need to control the
spread of resistance to these antibiotics, because with the
development of resistance to carbapenems, the treatment of
Gram-negative bacteria that produce β-lactams will be a
major problem.nses/by-nc-nd/4.0/).
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